Works matching DE "GLUCAGON-like peptide 1"
Results: 3000
Postprandial Adiponectin Levels Are Associated with Improvements in Postprandial Triglycerides After Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients.
- Published in:
- Metabolic Syndrome & Related Disorders, 2013, v. 11, n. 5, p. 343, doi. 10.1089/met.2012.0042
- By:
- Publication type:
- Article
Discovery of a potential positive allosteric modulator of glucagon-like peptide 1 receptor through virtual screening and experimental study.
- Published in:
- Journal of Computer-Aided Molecular Design, 2019, v. 33, n. 11, p. 973, doi. 10.1007/s10822-019-00254-4
- By:
- Publication type:
- Article
Obesity and cancer.
- Published in:
- Cancer & Metastasis Reviews, 2022, v. 41, n. 3, p. 463, doi. 10.1007/s10555-022-10049-z
- By:
- Publication type:
- Article
Improved transplantation outcome through delivery of DNA encoding secretion signal peptide-linked glucagon-like peptide-1 into mouse islets.
- Published in:
- Transplant International, 2013, v. 26, n. 4, p. 443, doi. 10.1111/tri.12052
- By:
- Publication type:
- Article
Liraglutide in islet transplantation: from bench to bedside.
- Published in:
- Transplant International, 2010, v. 23, n. 3, p. 257, doi. 10.1111/j.1432-2277.2009.01018.x
- By:
- Publication type:
- Article
Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture.
- Published in:
- Transplant International, 2010, v. 23, n. 3, p. 259, doi. 10.1111/j.1432-2277.2009.00984.x
- By:
- Publication type:
- Article
Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2002, v. 29, n. 5, p. 597, doi. 10.1007/s00259-002-0761-1
- By:
- Publication type:
- Article
The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 1, p. 127, doi. 10.1007/s00228-023-03586-1
- By:
- Publication type:
- Article
Association between glucagon-like peptide-1 receptor gene polymorphism and treatment response to GLP1R agonists in Chinese patients with type 2 diabetes: a prospective cohort study.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 5, p. 793, doi. 10.1007/s00228-021-03249-z
- By:
- Publication type:
- Article
New Phase 3 Trials Investigate Survodutide as a Promising Treatment for Obesity.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
ObesityWeek 2024: Viking Therapeutics Presents New Positive Data from VK2735 Obesity Program: Results from the VENTURE phase 2 trial and a phase I oral formulation study found that VK2735, a dual GLP-1 and GIP receptor agonist, demonstrated promise in treating obesity
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
GLP-1RAs Reduce the Risk of Early-Onset Colorectal Cancer in Adults with T2D.
- Published in:
- Patient Care (Online), 2024, p. 4
- By:
- Publication type:
- Article
GLP-1RAs Reduce Suicide Risk in Youth with Obesity: Daily Dose.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Exclusive Physician Survey Results on GLP-1 Receptor Agonists: The Hype Is Real.
- Published in:
- Patient Care (Online), 2024, p. 1
- Publication type:
- Article
Novel GLP-1 RA for Obesity Shows Promise in Early Phase 1 Trial.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Tirzepatide Tied to Lower Risk for Death, Adverse CV and Kidney Outcomes vs GLP-1s: Daily Dose.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
GLP-1RAs, SGLT-2 Inhibitors Tied to Lower Adverse Cardiovascular and Liver Events in Persons with T2D, MASLD.
- Published in:
- Patient Care (Online), 2024, p. 3
- By:
- Publication type:
- Article
New Online Tracker May Help Patients Find GLP-1RA Medication More Easily.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Semaglutide Explored for Treatment of Alcohol, Nicotine Use Disorders.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Real-World Studies Show Significant HbA1c Reductions with GLP-1 RA and Freestyle Libre CGM Used Together.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Viking Therapeutics Dual GIP/GLP-1 Mimetic Drives Weight Loss of Up to 14.7% in Phase 2 Findings.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Effect of Glucagon-like Peptide-1 on the Differentiation of Adipose-derived Stem Cells into Osteoblasts and Adipocytes.
- Published in:
- Journal of Menopausal Medicine, 2020, v. 26, n. 2, p. 93, doi. 10.6118/jmm.2015.21.2.93
- By:
- Publication type:
- Article
Effect of Glucagon-like Peptide-1 on the Differentiation of Adipose-derived Stem Cells into Osteoblasts and Adipocytes.
- Published in:
- Journal of Menopausal Medicine, 2015, v. 21, n. 2, p. 93, doi. 10.6118/jmm.2015.21.2.93
- By:
- Publication type:
- Article
Combined GLP-1 Receptor Agonist and Amylin Analogue Pharmacotherapy to Treat Obesity Comorbid With Type 1 Diabetes.
- Published in:
- JCEM Case Reports, 2023, v. 1, n. 2, p. 1, doi. 10.1210/jcemcr/luad040
- By:
- Publication type:
- Article
Correction to “Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes” (J Clin Endo Metab Case Reports. 2023; 1(1): 10.1210/jcemcr/luac017).
- Published in:
- JCEM Case Reports, 2023, v. 1, n. 1, p. 1, doi. 10.1210/jcemcr/luad005
- Publication type:
- Article
Correction to “Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes”.
- Published in:
- 2023
- Publication type:
- Correction Notice
Direct Effect of the Synthetic Analogue of Glucagon-Like Peptide Type 1, Liraglutide, on Mature Adipocytes Is Realized through Adenylate-Cyclase-Dependent Enhancing of Insulin Sensitivity.
- Published in:
- Biochemistry (00062979), 2021, v. 86, n. 3, p. 350, doi. 10.1134/S000629792103010X
- By:
- Publication type:
- Article
CIRURGIA METABÓLICA COMO TRATAMENTO CIRÚRGICO DO DIABETES TIPO II.
- Published in:
- Revista Foco (Interdisciplinary Studies Journal), 2023, v. 16, n. 9, p. 1, doi. 10.54751/revistafoco.v16n9-098
- By:
- Publication type:
- Article
Bitter Taste in the Treatment ofHeart Diseases from Avicenna's Point of View.
- Published in:
- Traditional & integrative Medicine, 2024, v. 9, n. 2, p. 190, doi. 10.18502/tim.vri2.t5872
- By:
- Publication type:
- Article
Does GLP-1 suppress its own basal secretion?
- Published in:
- Endocrine Research, 2016, v. 41, n. 1, p. 16, doi. 10.3109/07435800.2015.1038353
- By:
- Publication type:
- Article
Effects of exenatide therapy on insulin resistance in the skeletal muscles of high-fat diet and low-dose streptozotocin-induced diabetic rats.
- Published in:
- Endocrine Research, 2016, v. 41, n. 1, p. 1, doi. 10.3109/07435800.2015.1015726
- By:
- Publication type:
- Article
Paradigm shift in obesity treatment: an extensive review of current pipeline agents.
- Published in:
- Turkish Journal of Medical Sciences, 2025, v. 55, n. 1, p. 1, doi. 10.55730/1300-0144.5938
- By:
- Publication type:
- Article
The association between the route of nutrition and serum levels of adipokines in critical illness: a pilot study.
- Published in:
- Turkish Journal of Medical Sciences, 2020, v. 50, n. 4, p. 877, doi. 10.3906/sag-1911-165
- By:
- Publication type:
- Article
Pharmacotherapy for the management of obesity.
- Published in:
- Medicine Today, 2023, v. 24, n. 3, p. 61
- By:
- Publication type:
- Article
2022 ABSTRACTS OF THE AsMA SCIENTIFIC SESSIONS.
- Published in:
- 2022
- Publication type:
- Abstract
Glucagon-Like Peptide-1 Receptor Signaling in the Lateral Parabrachial Nucleus Contributes to the Control of Food Intake and Motivation to Feed.
- Published in:
- Neuropsychopharmacology, 2014, v. 39, n. 9, p. 2233, doi. 10.1038/npp.2014.74
- By:
- Publication type:
- Article
Combination approaches to reduce weight-gain induced by antipsychotics.
- Published in:
- European Psychiatry, 2021, v. 64, p. S32, doi. 10.1192/j.eurpsy.2021.111
- By:
- Publication type:
- Article
Network meta-analysis of the risk of dyspepsia and anorexia in patients with type 2 diabetes mellitus induced by glucagon-like peptide 1 receptor agonist hypoglycemic drugs.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2024, v. 28, n. 8, p. 3073
- By:
- Publication type:
- Article
The role of gut hormonal aspect in Iraqi patients subjected to sleeve Gastrectomy.
- Published in:
- Baghdad Science Journal, 2024, v. 21, n. 11, p. 3438, doi. 10.21123/bsj.2024.8990
- By:
- Publication type:
- Article
Dulaglutide Reduces Binge Eating in Patients with Type 2 Diabetes.
- Published in:
- Eating Disorders Review, 2020, v. 31, n. 4, p. N.PAG
- Publication type:
- Article
DPP-IV Inhibitors from natural sources: An alternative approach for treatment and management of diabetes.
- Published in:
- Indian Journal of Natural Products & Resources, 2019, v. 10, n. 4, p. 227
- By:
- Publication type:
- Article
Effects of GLP-1 Receptor Agonists on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus: A 52-Week Clinical Study.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/3361309
- By:
- Publication type:
- Article
Abrus precatorius Leaf Extract Reverses Alloxan/Nicotinamide-Induced Diabetes Mellitus in Rats through Hormonal (Insulin, GLP-1, and Glucagon) and Enzymatic (α-Amylase/α-Glucosidase) Modulation.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/9920826
- By:
- Publication type:
- Article
Emodin Attenuated the Kidney Damage of High-Fat-Diet Mice via the Upregulation of Glucagon-Like Peptide-1 Receptor.
- Published in:
- BioMed Research International, 2021, p. 1, doi. 10.1155/2021/6662704
- By:
- Publication type:
- Article
Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues.
- Published in:
- JRSM Cardiovascular Disease, 2015, v. 4, p. 1, doi. 10.1177/2048004015576008
- By:
- Publication type:
- Article
G Protein-Coupled Receptor 17 Inhibits Glucagon-like Peptide-1 Secretion via a Gi/o-Dependent Mechanism in Enteroendocrine Cells.
- Published in:
- Biomolecules (2218-273X), 2025, v. 15, n. 1, p. 9, doi. 10.3390/biom15010009
- By:
- Publication type:
- Article
Tirzepatide—Friend or Foe in Diabetic Cancer Patients?
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 11, p. 1580, doi. 10.3390/biom12111580
- By:
- Publication type:
- Article
Decoding endocrine cell differentiation: insights from high‐throughput CRISPR screening in human gut organoids.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 1, p. 1, doi. 10.1002/ctm2.1526
- By:
- Publication type:
- Article
Changes in glucagon‐like peptide 1 and 2 levels in people with obesity after a diet‐induced weight‐loss intervention are related to a specific microbiota signature: A prospective cohort study.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 11, p. 1, doi. 10.1002/ctm2.575
- By:
- Publication type:
- Article
Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy.
- Published in:
- HIV Medicine, 2005, v. 6, n. 2, p. 91, doi. 10.1111/j.1468-1293.2005.00270.x
- By:
- Publication type:
- Article